drugset
drugset / Trial / NCT04094025

Irritation and Sensitization Study of d-Amphetamine Transdermal System

NCT04094025 ↗

Phase 1 Completed 229 enrolled Noven Therapeutics
NaSingle-groupOpen-labelOther

Summary

The study will assess skin irritation as well as sensitization for d-ATS patch in healthy subjects.

Timeline

Start
2019-12-02
Primary completion
2020-05-16
Completion
2020-05-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextroamphetamine Small molecule — Topical

Indications

No indication recorded.